ArticleJournal of surgical oncology2022
Rural-urban survival disparities for patients with surgically treated lung cancer.
Article in Journal of surgical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Racial and ethnic disparities in receipt of guideline-concordant treatment for early-stage non-small cell lung cancer.Cancer causes & control : CCC · 2026Article
- Multifactorial Impact of Age, Race, and Female Sex on Management of Non-small Cell Lung Cancer.Annals of surgical oncology · 2026Article
- Implementation of a lung cancer screening program at an urban safety-net hospital: enabling solutions via stakeholder engagement.Frontiers in public health · 2026Article
- Urban-rural residence location and cancer-specific mortality among colorectal, lung and ovarian cancer patients: a nationwide retrospective cohort study from Lithuania.Acta oncologica (Stockholm, Sweden) · 2025Article
- Review
- Subspecialization of Surgical Specialties in the US.JAMA health forum · 2025Article
- Wait times between lung cancer diagnosis and surgery: national trends, disparities, and impact on long-term survival.Journal of thoracic disease · 2025Article
- Article
- Geographic Access to Cancer Care and Treatment and Outcomes of Early-Stage Non-Small Cell Lung Cancer.JAMA network open · 2025Article
- Impact of Medicaid expansion on stage of diagnosis of lung cancer for rural and urban patients in New Hampshire.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025Article
- Review
- Area-based disparities in non-small-cell lung cancer survival.Acta oncologica (Stockholm, Sweden) · 2024Article
- Health inequities across the lung cancer care continuum in ten marginalized populations: a narrative review.Journal of thoracic disease · 2023Review
- Evaluation of Nationwide Trends in Nodal Sampling Guideline Adherence for Gastric Cancer: 2005-2017.The Journal of surgical research · 2023Article
- Association between travel distance and overall survival among patients with adrenocortical carcinoma.Journal of surgical oncology · 2023Article
- Article
- Rural-urban survival disparities for patients with surgically treated lung cancer.Journal of surgical oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundNonsmall-cell lung cancer (NSCLC) is a common diagnosis among patients living in rural areas and small towns who face unique challenges accessing care. We examined differences in survival for surgically treated rural and small-town patients compared to those from urban and metropolitan areas.
methodsThe National Cancer Database was used to identify surgically treated NSCLC patients from 2004 to 2016. Patients from rural/small-town counties were compared to urban/metro counties. Differences in patient clinical, sociodemographic, hospital, and travel characteristics were described. Survival differences were examined with Kaplan-Meier curves and Cox proportional hazards models.
resultsThe study included 366 373 surgically treated NSCLC patients with 12.4% (n = 45 304) categorized as rural/small-town. Rural/small-town patients traveled farther for treatment and were from areas characterized by lower income and education(all p < 0.001). Survival probabilities for rural/small-town patients were worse at 1 year (85% vs. 87%), 5 years (48% vs. 54%), and 10 years (26% vs. 31%) (p < 0.001). Travel distance >100 miles (hazard ratio [HR] = 1.11, 95% confidence interval [CI]: 1.07-1.16, vs. <25 miles) and living in a rural/small-town county (HR = 1.04, 95% CI: 1.01-1.07) were associated with increased risk for death.
conclusionsRural and small-town patients with surgically treated NSCLC had worse survival outcomes compared to urban and metropolitan patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.